These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21639134)
1. Discovery and optimization of sulfonyl acrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1. Bachovchin DA; Zuhl AM; Speers AE; Wolfe MR; Weerapana E; Brown SJ; Rosen H; Cravatt BF J Med Chem; 2011 Jul; 54(14):5229-36. PubMed ID: 21639134 [TBL] [Abstract][Full Text] [Related]
2. Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors. Bachovchin DA; Mohr JT; Speers AE; Wang C; Berlin JM; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Schürer SC; Nomura DK; Rosen H; Fu GC; Cravatt BF Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6811-6. PubMed ID: 21398589 [TBL] [Abstract][Full Text] [Related]
3. Competitive activity-based protein profiling identifies aza-β-lactams as a versatile chemotype for serine hydrolase inhibition. Zuhl AM; Mohr JT; Bachovchin DA; Niessen S; Hsu KL; Berlin JM; Dochnahl M; López-Alberca MP; Fu GC; Cravatt BF J Am Chem Soc; 2012 Mar; 134(11):5068-71. PubMed ID: 22400490 [TBL] [Abstract][Full Text] [Related]
4. A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A. Ogris E; Du X; Nelson KC; Mak EK; Yu XX; Lane WS; Pallas DC J Biol Chem; 1999 May; 274(20):14382-91. PubMed ID: 10318862 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spread. Shen Y; Zificsak CA; Shea JE; Lao X; Bollt O; Li X; Lisko JG; Theroff JP; Scaife CL; Ator MA; Ruggeri BA; Dorsey BD; Kuwada SK J Med Chem; 2015 Feb; 58(3):1140-58. PubMed ID: 25581261 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide redistributes the localization of protein phosphatase methylesterase 1. Tang S; Lu C; Mo L; Wang X; Liang Z; Qin F; Liu Y; Liu Y; Huang H; Huang Y; Cai H; Xiao D; Guo S; Ouyang Y; Sun B; Li X Life Sci; 2018 Nov; 213():166-173. PubMed ID: 30340029 [TBL] [Abstract][Full Text] [Related]
7. The luciferase-based in vivo protein-protein interaction assay revealed that CHK1 promotes PP2A and PME-1 interaction. Ando S; Tanaka K; Matsumoto M; Oyama Y; Tomabechi Y; Yamagata A; Shirouzu M; Nakagawa R; Okimoto N; Taiji M; Sato K; Ohama T J Biol Chem; 2024 May; 300(5):107277. PubMed ID: 38588804 [TBL] [Abstract][Full Text] [Related]
8. Reduced Expression of the PP2A Methylesterase, PME-1, or the PP2A Methyltransferase, LCMT-1, Alters Sensitivity to Beta-Amyloid-Induced Cognitive and Electrophysiological Impairments in Mice. Staniszewski A; Zhang H; Asam K; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE J Neurosci; 2020 Jun; 40(23):4596-4608. PubMed ID: 32341098 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models. Pusey M; Bail S; Xu Y; Buiakova O; Nestor M; Yang JJ; Rice LM Tumour Biol; 2016 Sep; 37(9):11835-11842. PubMed ID: 27048286 [TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of the PME-1 gene causes loss of demethylated PP2A and perinatal lethality in mice. Ortega-Gutiérrez S; Leung D; Ficarro S; Peters EC; Cravatt BF PLoS One; 2008 Jul; 3(7):e2486. PubMed ID: 18596935 [TBL] [Abstract][Full Text] [Related]
11. Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile. Wu YJ; He H; Hu S; Huang Y; Scola PM; Grant-Young K; Bertekap RL; Wu D; Gao Q; Li Y; Klakouski C; Westphal RS J Med Chem; 2003 Nov; 46(23):4834-7. PubMed ID: 14584934 [TBL] [Abstract][Full Text] [Related]
12. Spatial control of protein phosphatase 2A (de)methylation. Longin S; Zwaenepoel K; Martens E; Louis JV; Rondelez E; Goris J; Janssens V Exp Cell Res; 2008 Jan; 314(1):68-81. PubMed ID: 17803990 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase. Grunewald GL; Seim MR; Regier RC; Martin JL; Gee CL; Drinkwater N; Criscione KR J Med Chem; 2006 Sep; 49(18):5424-33. PubMed ID: 16942016 [TBL] [Abstract][Full Text] [Related]
14. Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1. Kaur A; Westermarck J Biochem Soc Trans; 2016 Dec; 44(6):1683-1693. PubMed ID: 27913678 [TBL] [Abstract][Full Text] [Related]
15. PME-1 modulates protein phosphatase 2A activity to promote the malignant phenotype of endometrial cancer cells. Wandzioch E; Pusey M; Werda A; Bail S; Bhaskar A; Nestor M; Yang JJ; Rice LM Cancer Res; 2014 Aug; 74(16):4295-305. PubMed ID: 24928782 [TBL] [Abstract][Full Text] [Related]
16. Sulfonyl group-containing compounds in the design of potential drugs for the treatment of diabetes and its complications. Chen X; Hussain S; Parveen S; Zhang S; Yang Y; Zhu C Curr Med Chem; 2012; 19(21):3578-604. PubMed ID: 22664250 [TBL] [Abstract][Full Text] [Related]
17. Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice. Gnanaprakash M; Staniszewski A; Zhang H; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE J Alzheimers Dis; 2021; 79(4):1813-1829. PubMed ID: 33459709 [TBL] [Abstract][Full Text] [Related]
18. Methylation of the C-terminal leucine residue of the PP2A catalytic subunit is unnecessary for the catalytic activity and the binding of regulatory subunit (PR55/B). Ikehara T; Ikehara S; Imamura S; Shinjo F; Yasumoto T Biochem Biophys Res Commun; 2007 Mar; 354(4):1052-7. PubMed ID: 17274953 [TBL] [Abstract][Full Text] [Related]